Post Reply
1321-1340 of 10899
1.80 TP? abit hard lah.... mayb hit 1.4~1.5
1.8 mayb next year oct then possible
Important to note that biosensors has solid fundamentals: no debt , large cash balance, hi net margin of 35%, strong mkt share with continued growth in key geographies and strong cash flow.
Company is at least 4 years ahead of its competitors with its offering of the ' gold standard 'drug eluting stent .
At current levels stock is very undervalued and as a result the company launched a buyback program mandated for a maximum of172m shares .
Thus far Nomura has maintained a 1.80 price target which based on numbers and prospect for the company does not look demanding.
Hi tea,
Bishan has mentioned the tgt 116 . Today closed 112.5 . company buy back at 1.1007 which could form the logical support at 1.10. 1.12 was the resistant which broke near closing. 112 likely to be resistance turned support.
Buy at support sell at resistance. Need to watch tomorrow price and volume action as it has turned from near bottom and broke first resistance .......... perhaps buying when it pullback would be a strategy. Buying when it is rallying up only if the market sentiment for tomorrow is good. Remember that many bought today and might take profit tomorrow.
tea444u ( Date: 26-Nov-2012 18:29) Posted:
hi oppa, wondering if safe to vest inthis one for now? defensive stock... and your prediction...thanks
oppa49 ( Date: 26-Nov-2012 17:29) Posted:
| Tomorrow if it can break 115.5 then confirmed reversal. It will rally to the 119.5- 123 range again |
|
|
|
since most feel it is defensive stock, what are your TPs?
Need to test 1.16 again. Good luck.
hi oppa, wondering if safe to vest inthis one for now? defensive stock... and your prediction...thanks
oppa49 ( Date: 26-Nov-2012 17:29) Posted:
Tomorrow if it can break 115.5 then confirmed reversal. It will rally to the 119.5- 123 range again.
junction ( Date: 26-Nov-2012 17:01) Posted:
|
|
|
Number of shares held as treasury shares (Singapore Exchange):
1,653,000
Number of shares held as treasury shares (Overseas Exchange):
Price paid per share# currency (Singapore Exchange):
S$
Price paid per share# currency (Overseas Exchange):
Price paid per share# amount (Singapore Exchange):
1.1007
another buy back.... foundation of stock is set hard..... woohoo up we go~~~ faster up up up!!!
As expected the first buyback was Nov 8 at about $1.11...matter of time when selling pressure dries up ,hence today closed at $1.125..
Tomorrow if it can break 115.5 then confirmed reversal. It will rally to the 119.5- 123 range again.
junction ( Date: 26-Nov-2012 17:01) Posted:
Looks like a breakout!
steadylar ( Date: 26-Nov-2012 16:47) Posted:
| Wow, suddenly come alive again and running up, buy some! |
|
|
|
letss wait for 5.30 to see today got share buy back a not
Looks like a breakout!
steadylar ( Date: 26-Nov-2012 16:47) Posted:
| Wow, suddenly come alive again and running up, buy some! |
|
Up up here we go!
ya lor, me went to koon a while, wake up chiong 0.04.... wee~~~~ black le... more to come!!
Wow, suddenly come alive again and running up, buy some!
first timee i see 0.015 growth..... more to come!!!
Maybe if it dropped to $1.02 to 41.05 then buy more but now $1.08 can accumulate slowly..by Jan 1 all fiscal cliff problems will surely be solved..at the rate Biosensor is buying back its stocks,means more of its shares taken off the market,it takes an impetus b4 buyers appear in droves to drive up the stock again..next accounting figures will show EPS up at expoential rate as treasury shares normally excluded in such calculations
steadylar ( Date: 25-Nov-2012 21:03) Posted:
Hi scimitar, dont buy yet until there's clear sign of demand for this stock.
Generally for all mkts, as the earning season comes to an end, and funds start to unwind their position and go on year end holidays, the mkts will get very quiet. We should take a break too after this week, and come back to the mkt after Christmas. Without any news or catalyst, bios will likely remain weak and range around this level. Hopefully it'll bounce back in Jan in expectation for the next earnings season.
|
|
| Written by Dow Jones & Co, Inc |
| Monday, 26 November 2012 12:52 |
Nomura tips Singapore equities face a subdued 2013 outlook, forecasting single-digit returns as economic restructuring drags earnings and as a sharp property-market pullback could undermine returns.
It views consensus estimates for 11% FY13 market EPS growth as too optimistic. But it adds, the market is “not expensive” at 1.4x FY13 book value vs its 1.7x long-term average and at 12.5x FY13 P/E vs its 12x-18x 15-year range.
“We are Bullish on conglomerates as we see the sector generating steady earnings growth that can support dividends. We are Bearish on gaming, given the strict policy regime, while developers are likely to underperform as fundamentals deteriorate. We are Neutral on banks on valuation grounds, while telcos and S-REITs are supported by dividend yields.”
It tips companies generating more earnings overseas than domestically and with defensive dividend yields, favouring Keppel (BN4.SG), Sembcorp (U96.SG) and ST Engineering (S63.SG). It likes Jardine Matheson (J36.SG), noting mostly ex-Singapore earnings.
It likes SATS’ (S58.SG) and ComfortDelGro’s (C52.SG) steady earnings and yields. It tips DBS (D05.SG) and Keppel Land (K17.SG) for attractive valuations and North Asia optionality.
Among cyclicals, it prefers First Resources (EB5.SG) on Nomura’s positive CPO-price outlook, and likes Bumitama (P8Z.SG). Among S-REITs, it tips Ascendas Hospitality Trust (Q1P.SG), with Biosensors (B20.SG) its healthcare pick.
|
Ok, wait one more month for next earning season. Let's hope it jumps to 1.65.
Hi scimitar, dont buy yet until there's clear sign of demand for this stock.
Generally for all mkts, as the earning season comes to an end, and funds start to unwind their position and go on year end holidays, the mkts will get very quiet. We should take a break too after this week, and come back to the mkt after Christmas. Without any news or catalyst, bios will likely remain weak and range around this level. Hopefully it'll bounce back in Jan in expectation for the next earnings season.
